ISPE Announces 2020–2021 International Board of Directors

The International Society for Pharmaceutical Engineering (ISPE) announced its 2020–2021 International Board of Directors during the virtual 2020 ISPE Annual Meeting & Expo on Nov. 6, 2020.

According to an ISPE press release, the new board consists of:

Officers:

• Chair: Joanne Barrick, RPh, Advisor, Global Validation, Eli Lilly and Company
• Vice Chair: Jörg Zimmermann, vice president, Vetter Development Service, External Affairs, Vetter Pharma Fertigung GmbH&Co KG
• Treasurer: Michael Rutherford, executive director, Computer Systems Quality & Data Integrity, Syneos Health
• Secretary: Scott Billman, global head of Engineering, Biogen
• Past Chair: Frances Zipp, president and CEO, Lachman Consultant Services, Inc.

Directors Elected to a Second Term:

• Vivianne Arencibia, independent consultant, Arencibia Quality Compliance Associates
• Chris Chen, PhD, CEO, WuXi Biologics (Shanghai) Co., Ltd.

New Directors:

• Nina Cauchon, PhD, director, Regulatory Affairs - CMC, Amgen Inc.
• David Doleski, compliance head for Biologics Quality Operations, Sanofi (Appointed director)
• Teresa Minero, founder and CEO, LifeBee - Digitalizing Life Sciences
• Hirofumi Suzuki, PhD, senior regulatory CMC adviser, Bayer Yakuhin Ltd

Continuing Board Members:

• Ylva Ek, chief quality officer, KeyPlants AB
• Lou Kennedy, CEO and owner, Nephron Pharmaceuticals
• Stephen Mahoney, JD, senior director, Global Quality & Compliance, Genentech, a member of the Roche Group
• Alice Redmond, PhD, vice president, European Operations, CAI

Young Professionals Representative (Ex Officio):

• John Clarke, operations lead, Pfizer

Source: ISPE​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​​